APA (7th ed.) Citation

Y, B., YR, S., S, K., S, J., CH, K., & YH, L. (2026). From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy. Immune network, 26(1), e13. https://doi.org/10.4110/in.2026.26.e13

Chicago Style (17th ed.) Citation

Y, Baek, Seo YR, Kim S, Jung S, Kim CH, and Lee YH. "From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy." Immune Network 26, no. 1 (2026): e13. https://doi.org/10.4110/in.2026.26.e13.

MLA (9th ed.) Citation

Y, Baek, et al. "From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy." Immune Network, vol. 26, no. 1, 2026, p. e13, https://doi.org/10.4110/in.2026.26.e13.